Table 3.
Phenotypic and genotypic characteristics of Escherichia coli isolates.
| Isolate | Sequence Typing | ESBL | β-Lactamases | Originating Site | Source | Phenotypic Profile |
|---|---|---|---|---|---|---|
| 378 | 3 | + | CTX-M-group 9, TEM | H (Surg) | Wound | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, STX |
| 2724 | 3 | - | Outpatient | Urine | AMP, CEF | |
| 439 | 4 | - | H (Peds) | Urine | AMP, STX | |
| 1232 | 43 | + | CTX-M-group-1 (CTX-M-15) | H (Ort) | Wound | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, GEN, CIP |
| 2690 | 43 | + | CTX-M-group 9, TEM | Outpatient | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, NAL, CIP, STX |
| 0-3630 | 43 | + | CTX-M-group 9, TEM | Outpatient | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, NAL, CIP, STX |
| 640 | 53 | + | CTX-M group 9 | H (Surg) | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, CIP |
| 370 | 53 | - | H (Ob-Gyn) | Urine | AMP, TZP, CEF, CXM, CAZ, AMK, NAL, CIP | |
| 2685 | 53 | - | Outpatient | Urine | AMP, CEF, NAL, CIP, STX | |
| 2710 | 458 | + | CTX-M-group 9 | Outpatient | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, NAL, CIP, STX |
| 19-2410 | 458 | - | H (IM) | Blood | AMP, CIP, STX | |
| 2699 | 458 | - | Outpatient | Urine | AMP, CEF, NAL, CIP | |
| 3627 | 479 | - | H (Surg) | Urine | AMP, GEN, NAL, CIP, STX | |
| 382 | 526 | + | CTX-M-group-1 (CTX-M-15) | H (IM) | Wound | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, STX |
| HRV-09 | 594 | + | ND | I (ICU) | Wound | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, GEN, CIP, STX |
| 361 | 621 | + | CTX-M-group-1 (CTX-M-15) | H (IM) | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, CIP, STX |
| 2676 | 833 | + | CTX-M-group-1, TEM | Outpatient | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, GEN, NAL, CIP, STX |
| 542 | 833 | - | H (IM) | Blood | AMP, NAL, CIP, STX | |
| 375 | N/A | + | CTX-M-group-1 (CTX-M-15), TEM | H (Surg) | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, NAL, GEN, CIP |
| 638 | N/A | + | CTX-M-group-1 (CTX-M-15) | H (Surg) | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, GEN, CIP, STX |
| CC2 | N/A | + | CTX-M-group 9 | H (IM) | Urine | AMP, CEF, CFZ, CXM, CTX, CAZ, FEP, CIP, STX |
| 435, 655 | N/A | - | H(IM) | Urine | AMP, NAL, CIP, STX | |
| 543, 544 | N/A | - | H (Ob-Gyn) | Blood | AMP, NAL, CIP, STX | |
| 545 | N/A | - | H (IM) | Blood | AMP, CIP, STX | |
| O-2115 | N/A | - | Outpatient | Urine | AMP, CIP, STX | |
| CC1 | N/A | - | H (IM) | Urine | NAL | |
| 519 | N/A | - | H (Ob-Gyn) | Wound | AMP, NAL | |
| 436 | N/A | - | Outpatient | Urine | AMP |
AMP: ampicillin; AMK: amikacin; CAZ: ceftazidime; CEF: cephalothin; CFZ: cefazoline; CIP: ciprofloxacin; CTX: cefotaxime; CXM: cefuroxime; ESBL: extended-spectrum β-lactamase; FEP: cefepime; GEN: gentamicin; ICU: intensive care unit ward; IM: internal medicine ward; NAL: nalidixic acid; SXT: trimethoprim-sulfamethoxazole; TZP: piperacillin-tazobactam; ND: not detected; Ob-Gyn: obstetrics and gynecology ward; Ort: orthopedics ward; Peds: pediatric ward; Surg: surgery ward; +: ESBL; -: non-ESBL; N/A: not applicable.